Ligand Pharmaceuticals Incorporated

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
04/23/21 DEF 14A Definitive proxy statements HTML PDF 63
02/24/21 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
HTML PDF XBRL Viewer XLS XBRL Files 186
02/23/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/18/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/18/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/18/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/18/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/16/21 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 4
02/16/21 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 3
02/12/21 4 Statement of changes in beneficial ownership of securities HTML PDF 2
RSS